| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |